Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2021

Nov 16, 2021

32106_dirs_2021-11-15_e451170a-6548-45c3-bcf1-23ff8195ca9e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-11-04

Reporting Person: Wichterman Troy (Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1286 Direct
Common Stock 127 Direct
Common Stock 728 Direct
Common Stock 14644 Direct
Common Stock 5680 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option $2.0600 2025-05-04 Common Stock (938) Direct

Footnotes

F1: Restricted stock award granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests in equal quarterly installments.

F2: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.

F3: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.

F4: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.

F5: On May 4, 2015, the reporting person was granted an option to purchase 5,000 shares of common stock which vested in full on May 4, 2019 and of which 4,062 of such options have been exercised.